{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T22:10:03Z","timestamp":1736719803115,"version":"3.32.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s10354-006-0353-y","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T10:38:28Z","timestamp":1168252708000},"page":"644-656","source":"Crossref","is-referenced-by-count":10,"title":["Klinik, Diagnostik und Therapie HIV-induzierter neuropsychiatrischer St\u00f6rungen","Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders"],"prefix":"10.1007","volume":"156","author":[{"given":"Hans-Bernd","family":"Rothenh\u00e4usler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"353_CR1","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1126\/science.295.5559.1441a","volume":"295","author":"J Cohen","year":"2002","unstructured":"Cohen J (2002) AIDS research. Longtime rivalry ends in collaboration. Science 295: 1441\u20131442","journal-title":"Science"},{"issue":"Suppl 3","key":"353_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13550280500511782","volume":"11","author":"N Nakasujja","year":"2005","unstructured":"Nakasujja N, Musisi S, Robertson K, Wong M, Sacktor N, Ronald A (2005) Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol 11(Suppl 3): 26\u201329","journal-title":"J Neurovirol"},{"key":"353_CR3","first-page":"302","volume":"1","author":"JG Bartlett","year":"1993","unstructured":"Bartlett JG (1993) Human immunodeficiency virus infection. New Horiz 1: 302\u2013311","journal-title":"New Horiz"},{"key":"353_CR4","first-page":"189","volume":"18","author":"YG Rao","year":"2005","unstructured":"Rao YG, Mirza DF (2005) Infections transmitted from donors to recipients following organ transplantation. Natl Med J India 18: 189\u2013194","journal-title":"Natl Med J India"},{"key":"353_CR5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199010113231501","volume":"323","author":"MA Fischl","year":"1990","unstructured":"Fischl MA, Parker CB, Pettinelli C, Wulfsohn M, Hirsch MS, Collier AC, Antoniskis D, Ho M, Richman DD, Fuchs E (1990) A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clincial Trials Group. N Engl J Med 323: 1009\u20131014","journal-title":"N Engl J Med"},{"key":"353_CR6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM199508173330710","volume":"333","author":"DD Ho","year":"1995","unstructured":"Ho DD (1995) Time to hit HIV, early and hard. N Engl J Med 333: 450\u2013451","journal-title":"N Engl J Med"},{"key":"353_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","volume":"351","author":"DW Cameron","year":"1998","unstructured":"Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravcik S, Maurath C, Sun E, Henry D, Rode R, Potthoff A, Leonhard J (1998) Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 351: 543\u2013549","journal-title":"Lancet"},{"key":"353_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","volume":"362","author":"A Mocroft","year":"2003","unstructured":"Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Philipps AN, Lundgren JD, EuroSIDA study group (2003) Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362: 22\u201329","journal-title":"Lancet"},{"issue":"Suppl 3","key":"353_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13550280500513846","volume":"11","author":"C Manzardo","year":"2005","unstructured":"Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, Miro JM (2005) Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol 11(Suppl 3): 72\u201382","journal-title":"J Neurovirol"},{"issue":"Suppl 3","key":"353_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13550280600558923","volume":"11","author":"P Cinque","year":"2005","unstructured":"Cinque P, Robertson K, Antinori A, Price RW(2005) Neurological complications of HIV infection and AIDS: current and future perspectives. J Neurovirol 11(Suppl 3): 1\u20135","journal-title":"J Neurovirol"},{"issue":"Suppl 2","key":"353_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13550280290167948","volume":"8","author":"E Koutsilieri","year":"2002","unstructured":"Koutsilieri E, Scheller C, Sopper S, ter Meulen V, Riederer P (2002) Psychiatric complications in human immunodeficiency virus infection. J Neurovirol 8(Suppl 2): 129\u2013133","journal-title":"J Neurovirol"},{"issue":"Suppl 1","key":"353_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-200401001-00006","volume":"18","author":"CR Dolder","year":"2004","unstructured":"Dolder CR, Patterson TL, Jeste DV (2004) HIV, psychosis and aging: past, present and future. AIDS 18(Suppl 1): 35\u201342","journal-title":"AIDS"},{"key":"353_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s001150050740","volume":"72","author":"RW Von Einsiedel","year":"2001","unstructured":"Von Einsiedel RW, Berger T, Weisbrod M, Unverricht S, Hartmann M (2001) HIV-Patienten mit psychiatrischen Krankheiten. Nervenarzt 72: 204\u2013215","journal-title":"Nervenarzt"},{"key":"353_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1012840717735","volume":"73","author":"SJ Ferrando","year":"2002","unstructured":"Ferrando SJ, Wapenyi (2002) Psychopharmacological treatment of patients with HIV and AIDS. Psychiatr Q 73: 33\u201348","journal-title":"Psychiatr Q"},{"key":"353_CR15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00002030-200206140-00002","volume":"16","author":"GJ Treisman","year":"2002","unstructured":"Treisman GJ, Kaplin AI (2002) Neurologic and psychiatric complications of antiretroviral agents. AIDS 16: 1201\u20131215","journal-title":"AIDS"},{"key":"353_CR16","unstructured":"Centers for Disease Control and Prevention (CDC) (1992) 1993 Revision classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41(no. RR-17)"},{"key":"353_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM199302043280508","volume":"328","author":"G Pantaleo","year":"1993","unstructured":"Pantaleo G, Graziosi C, Fauci AS (1993) The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328: 327\u2013335","journal-title":"N Engl J Med"},{"key":"353_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2003-39118","volume":"128","author":"NH Brockmeyer","year":"2003","unstructured":"Brockmeyer NH (2003) Deutsch-\u00d6sterreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. Dtsch Med Wochenschr 128: 7\u201318","journal-title":"Dtsch Med Wochenschr"},{"key":"353_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.3277272","volume":"239","author":"RW Price","year":"1988","unstructured":"Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586\u2013592","journal-title":"Science"},{"key":"353_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1440-1614.1999.00574.x","volume":"33","author":"SR Ellen","year":"1999","unstructured":"Ellen SR, Judd FK, Mijch AM, Cockram A (1999) Secondary mania in patients with HIV infection. Aust N Z J Psychiatry 33: 353\u2013360","journal-title":"Aust N Z J Psychiatry"},{"key":"353_CR21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.158.5.725","volume":"158","author":"J Ciesla","year":"2001","unstructured":"Ciesla J, Roberts J (2001) Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 158: 725\u2013730","journal-title":"Am J Psychiatry"},{"key":"353_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/ajp.151.2.237","volume":"151","author":"DD Sewell","year":"1994","unstructured":"Sewell DD, Jeste DV, Atkinson JH, Heaton RK, Hesselink JR, Wiley C, Thal L, Chandler JL, Grant I (1994) HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. Am J Psychiatry 151: 237\u2013242","journal-title":"Am J Psychiatry"},{"key":"353_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1468-1293.2003.00142.x","volume":"4","author":"R Foster","year":"2003","unstructured":"Foster R, Olajide D, Everall I (2003) Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Med 4: 139\u2013144","journal-title":"HIV Med"},{"key":"353_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02036408","volume":"58","author":"K Bonhoeffer","year":"1917","unstructured":"Bonhoeffer K (1917) Die exogenen Reaktionstypen. Arch Psychiatr Nervenkr 58: 58\u201370","journal-title":"Arch Psychiatr Nervenkr"},{"key":"353_CR25","unstructured":"UNAIDS\/WHO (2005) AIDS epidemic update: December 2005. WHO Library, Geneva, S Abteilung. Deuticke, Leipzig Wien, S1\u2013S5"},{"key":"353_CR26","unstructured":"EuroHIV (2005) HIV\/AIDS surveillance in Europe: End-year-report 2004 (No. 71). Euro Surveill 10: E051124.1"},{"key":"353_CR27","first-page":"437","volume":"47","author":"Robert Koch-Institut","year":"2005a","unstructured":"Robert Koch-Institut (2005a) Zum Welt-AIDS-Tag 2005: Stand und Entwicklung der HIV-Epidemie in Deutschland. Epidemiol Bull 47: 437\u2013446","journal-title":"Epidemiol Bull"},{"key":"353_CR28","unstructured":"Puchhammer-St\u00f6ckl E, Heinz FX (2006) HIV 2005. Institut f\u00fcr Virologie der Medizinischen Universit\u00e4t Wien. Virusepidemiologische Information Nr. 04\/06-2"},{"key":"353_CR29","first-page":"171","volume-title":"Manual of psychiatric care for the medically ill","author":"AA Wyszynski","year":"2005","unstructured":"Wyszynski AA, Bruno B, Ying P, Chuang L, Friedlander M, Rubenstein B (2005) The HIV-infected patient. In: Wyszynski AA, Wyszynski B (Hrsg) Manual of psychiatric care for the medically ill. American Psychiatric Publishing, Arlington, pp 171\u2013200"},{"key":"353_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1025483806464","volume":"3","author":"SM Albert","year":"1999","unstructured":"Albert SM, Weber C, Todak G (1999) An observed performance test of medication management ability in HIV: relation to neuropsychological status and adherence outcomes. AIDS Behav 3: 121\u2013128","journal-title":"AIDS Behav"},{"key":"353_CR31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1017\/S1355617799577011","volume":"5","author":"TD Marcotte","year":"1999","unstructured":"Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, Ellis RJ, Grant I (1999) The impact of HIV-related neuropsychological dysfunction on driving behaviour. The HNRC Group. J Int Neuropsychol Soc 5: 579\u2013592","journal-title":"J Int Neuropsychol Soc"},{"key":"353_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","volume":"8","author":"N Sacktor","year":"2002","unstructured":"Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8: 136\u2013142","journal-title":"J Neurovirol"},{"key":"353_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1355617700000230","volume":"1","author":"RK Heaton","year":"1995","unstructured":"Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ (1995) The HNRC 500 \u2013 neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231\u2013251","journal-title":"J Int Neuropsychol Soc"},{"key":"353_CR34","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","volume":"43","author":"JC McArthur","year":"1993","unstructured":"McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245\u20132252","journal-title":"Neurology"},{"key":"353_CR35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","volume":"11","author":"HR Brodt","year":"1997","unstructured":"Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11: 1731\u20131738","journal-title":"AIDS"},{"key":"353_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","volume":"157","author":"McArthur","year":"2004","unstructured":"McArthur (2004) HIV dementia: an evolving disease. J Neuroimmunol 157: 3\u201310","journal-title":"J Neuroimmunol"},{"key":"353_CR37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/schbul\/22.3.465","volume":"22","author":"DD Sewell","year":"1996","unstructured":"Sewell DD (1996) Schizophrenia and HIV. Schizophr Bull 22: 464\u2013473","journal-title":"Schizophr Bull"},{"key":"353_CR38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1176\/ajp.150.2.326","volume":"150","author":"CG Lyketsos","year":"1993","unstructured":"Lyketsos CG, Hanson AL, Fishman M, Rosenblatt A, McHugh PR, Treisman GJ (1993) Manic syndrome early and late in the course of HIV. Am J Psychiatry 150: 326\u2013327","journal-title":"Am J Psychiatry"},{"key":"353_CR39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/archpsyc.1988.01800330091011","volume":"45","author":"JH Atkinson Jr","year":"1988","unstructured":"Atkinson JH Jr, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1988) Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry 45: 859\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"353_CR40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00006842-199209000-00006","volume":"54","author":"GR Brown","year":"1992","unstructured":"Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L (1992) Prevalence of psychiatric disorders in early stages of HIV infection. Psychosom Med 54: 588\u2013601","journal-title":"Psychosom Med"},{"key":"353_CR41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0010-440X(97)90067-5","volume":"38","author":"JG Rabkin","year":"1997","unstructured":"Rabkin JG, Ferrando SJ, Jacobsberg LB, Fishman B (1997) Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry 38: 146\u2013154","journal-title":"Compr Psychiatry"},{"key":"353_CR42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.153.11.1430","volume":"153","author":"CG Lyketsos","year":"1996","unstructured":"Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ (1996) Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 153: 1430\u20131437","journal-title":"Am J Psychiatry"},{"key":"353_CR43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-2003-40562","volume":"71","author":"HB Rothenh\u00e4usler","year":"2003","unstructured":"Rothenh\u00e4usler HB, Kapfhammer HP (2003) Depression bei k\u00f6rperlichen Erkrankungen \u2013 Diagnose und Therapie vor konsiliarpsychiatrischem Hintergrund. Fortschr Neurol Psychiatr 71: 358\u2013365","journal-title":"Fortschr Neurol Psychiatr"},{"key":"353_CR44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002030-199304000-00011","volume":"7","author":"RA Bornstein","year":"1993","unstructured":"Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ (1993) Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS 7: 519\u2013524","journal-title":"AIDS"},{"key":"353_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF03033817","volume":"8","author":"BA Navia","year":"2005","unstructured":"Navia BA, Rostasy K (2005) The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies. Neurotox Res 8: 3\u201324","journal-title":"Neurotox Res"},{"key":"353_CR46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00042560-199503010-00008","volume":"8","author":"C Power","year":"1995","unstructured":"Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr 8: 273\u2013278","journal-title":"J Acquir Immune Defic Syndr"},{"key":"353_CR47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/158.5.1079","volume":"158","author":"RW Price","year":"1992","unstructured":"Price RW, Brew B (1992) The AIDS dementia complex. J Infect Dis 158: 1079\u20131083","journal-title":"J Infect Dis"},{"key":"353_CR48","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/00002030-200309050-00008","volume":"17","author":"C Eggers","year":"2003","unstructured":"Eggers C, Hertogs K, St\u00fcrenburg HJ, van Lunzen J, Stellbrink HJ (2003) Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. AIDS 17: 1897\u20131906","journal-title":"AIDS"},{"key":"353_CR49","first-page":"S619","volume-title":"HIV.NET 2005","author":"C Eggers","year":"2005","unstructured":"Eggers C, Rosenkranz T (2005) HIV-Enzephalopathie und HIV-assoziierte Myelopathie. In: Hoffmann C, Rockstroh J, Kamps BS (Hrsg) HIV.NET 2005. Steinh\u00e4user, Wuppertal, S619\u2013S623"},{"key":"353_CR50","first-page":"275","volume":"78","author":"J Wagner-Jauregg","year":"1928","unstructured":"Wagner-Jauregg J (1928) Malariatherapie. Vortrag, gehalten im Rahmen des Internationalen Fortbildungskurses \u00fcber Syphilis und Hautkrankheiten am 16. Februar 1928. Wien Med Wochenschr 78: 275\u2013278","journal-title":"Wien Med Wochenschr"},{"key":"353_CR51","first-page":"369","volume":"52","author":"MJ Harris","year":"1991","unstructured":"Harris MJ, Jeste DV, Gleghorn A, Sewell DD (1991) New-onset psychosis in HIV-infected patients. J Clin Psychiatry 52: 369\u2013376","journal-title":"J Clin Psychiatry"},{"key":"353_CR52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.jcp.0000177848.85415.e9","volume":"25","author":"JC Huffman","year":"2005","unstructured":"Huffman JC, Fricchione GL (2005) Catatonia and psychosis in a patient with AIDS. J Clin Psychopharmacol 25: 508\u2013510","journal-title":"J Clin Psychopharmacol"},{"key":"353_CR53","unstructured":"Ayuso-Mateos JL (2000) Psychiatric aspects of infections. In: Gelder MG, Lopez-Ibor JJ Jr, Andreasen NC (Hrsg) New Oxford Textbook of Psychiatry. Band 2. Oxford, S1168\u2013S1173"},{"key":"353_CR54","first-page":"675","volume":"68","author":"EP Lesho","year":"2003","unstructured":"Lesho EP, Gey DC (2003) Managing issues related to antiretroviral therapy. Am Fam Physician 68: 675\u2013686","journal-title":"Am Fam Physician"},{"key":"353_CR55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00059-005-2737-y","volume":"30","author":"A Potthoff","year":"2005","unstructured":"Potthoff A, Brockmeyer (2005) Stand der HIV-Infektion 2005. Herz 30: 451\u2013457","journal-title":"Herz"},{"key":"353_CR56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1176\/jnp.9.2.277","volume":"9","author":"CG Lyketsos","year":"1997","unstructured":"Lyketsos CG, Schwartz J, Fishman M, Treisman G (1997) AIDS mania. J Neuropsychiatry Clin Neurosci 9: 277\u2013279","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"353_CR57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1176\/ajp.148.8.1068","volume":"148","author":"K Kieburtz","year":"1991","unstructured":"Kieburtz K, Zettelmaier AE, Ketonen L, Tuite M, Caine ED (1991) Manic syndromes in AIDS. Am J Psychiatry 148: 1068\u20131070","journal-title":"Am J Psychiatry"},{"key":"353_CR58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1176\/jnp.11.4.475","volume":"11","author":"AM Mijch","year":"1999","unstructured":"Mijch AM, Judd FK, Lyketsos CG, Ellen S, Cockram A (1999) Secondary mania in patients with HIV infection: are antiretrovirals protective? J Neuropsychiatry Clin Neurosci 11: 475\u2013480","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"353_CR59","first-page":"239","volume":"2","author":"PR McHugh","year":"1989","unstructured":"McHugh PR (1989) The neuropsychiatry of basal ganglia disorder: A triadic syndrome and its explanation. Neuropsychiatry Neuropsychol Behav Neurol 2: 239\u2013247","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"353_CR60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1520-6394(1998)7:4<178::AID-DA6>3.0.CO;2-6","volume":"7","author":"G Treisman","year":"1998","unstructured":"Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C (1998) Mood disorders in HIV infection. Depress Anxiety 7: 178\u2013187","journal-title":"Depress Anxiety"},{"key":"353_CR61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2005-923518","volume":"34","author":"A Willer","year":"2005","unstructured":"Willer A, Sau\u00dfele S (2005) Individualisierte Therapie der HIV-Infektion. Klinikarzt 34: 319\u2013322","journal-title":"Klinikarzt"},{"key":"353_CR62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0272-7358(97)00021-4","volume":"17","author":"JS McDaniel","year":"1997","unstructured":"McDaniel JS, Purcell DW, Farber EW (1997) Severe mental illness and HIV-related medical and neuropsychiatric sequelae. Clin Psychol Rev 17: 311\u2013325","journal-title":"Clin Psychol Rev"},{"key":"353_CR63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1212\/WNL.54.1.233","volume":"54","author":"N Sacktor","year":"2000","unstructured":"Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K (2000) Transdermal selegiline in HIV-associated cognitive impairment: a pilot, placebo-controlled study. Neurology 54: 233\u2013235","journal-title":"Neurology"},{"key":"353_CR64","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","volume":"293","author":"MC Zink","year":"2005","unstructured":"Zink MC, Uhrlaub J, DeWitt, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293: 2003\u20132011","journal-title":"JAMA"},{"key":"353_CR65","unstructured":"Robert Koch-Institut (2005) HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Epidemiol Bull (Sonderausgabe A: 1\u201316)"},{"key":"353_CR66","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00002030-199607000-00007","volume":"10","author":"CA Wiley","year":"1996","unstructured":"Wiley CA, Baldwin M, Achim CL (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843\u2013847","journal-title":"AIDS"},{"key":"353_CR67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1531-8257(199901)14:1<128::AID-MDS1021>3.0.CO;2-J","volume":"14","author":"G Lera","year":"1999","unstructured":"Lera G, Zirulnik J (1999) Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism. Mov Disord 14: 128\u2013131","journal-title":"Mov Disord"},{"key":"353_CR68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1176\/jnp.10.1.111","volume":"10","author":"A Maha","year":"1998","unstructured":"Maha A, Goetz K (1998) Risperidone for the treatment of delusional disorder due to HIV. J Neuropsychiatry Clin Neurosci 10: 111","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"353_CR69","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-2007-979320","volume":"31","author":"M Dettling","year":"1998","unstructured":"Dettling M, M\u00fcller-Oerlinghausen B, Britsch P (1998) Clozapine treatment of HIV-associated psychosis \u2013 too much bone marrow toxicity? Pharmacopsychiatry 31: 156\u2013157","journal-title":"Pharmacopsychiatry"},{"key":"353_CR70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3999(96)00373-X","volume":"42","author":"AN Singh","year":"1997","unstructured":"Singh AN, Golledge H, Catalan J (1997) Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases. J Psychosom Res 42: 489\u2013493","journal-title":"J Psychosom Res"},{"key":"353_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10354-005-0195-z","volume":"155","author":"HB Rothenh\u00e4usler","year":"2005","unstructured":"Rothenh\u00e4usler HB, Kapfhammer HP (2005) Psychopharmakotherapie bei somatischen Erkrankungen \u2013 Behandlungsprinzipien in der medizinischen Routineversorgung. Wien Med Wochenschr 155: 1\u201312","journal-title":"Wien Med Wochenschr"},{"key":"353_CR72","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00005053-199308000-00009","volume":"181","author":"J Tanquary","year":"1993","unstructured":"Tanquary J (1993) Lithium-induced neurotoxicity at therapeutic levels in an AIDS patient. J Nerv Ment Dis 181: 518\u2013519","journal-title":"J Nerv Ment Dis"},{"key":"353_CR73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/322679","volume":"33","author":"A Angelino","year":"2001","unstructured":"Angelino A, Treisman G (2001) Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis 33: 847\u2013856","journal-title":"Clin Infect Dis"},{"key":"353_CR74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0193-953X(03)00056-X","volume":"25","author":"M Robinson","year":"2002","unstructured":"Robinson M, Qaqish R (2002) Practical psychopharmacology in HIV-1 and acquired immunodefciency syndrome. Psychiatr Clin North Am 25: 149\u2013175","journal-title":"Psychiatr Clin North Am"},{"key":"353_CR75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2004-828330","volume":"32","author":"J Thome","year":"2005","unstructured":"Thome J, Kopf D (2005) Blutbildver\u00e4nderungen unter Antipsychotika der zweiten Generation. Psychiatr Prax 32: 167\u2013171","journal-title":"Psychiatr Prax"},{"key":"353_CR76","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(94)91694-2","volume":"344","author":"AN Singh","year":"1994","unstructured":"Singh AN, Catalan J (1994) Risperidone in HIV-related manic psychosis. Lancet 344: 1029\u20131030","journal-title":"Lancet"},{"key":"353_CR77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/jnp.5.4.430","volume":"5","author":"MH Halman","year":"1993","unstructured":"Halman MH, Worth JL, Sanders KM, Renshaw PF, Murray GB (1993) Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 5: 430\u2013434","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"353_CR78","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4088\/JCP.v58n0906h","volume":"58","author":"JA RachBeisel","year":"1997","unstructured":"RachBeisel JA, Weintraub E (1997) Valproic acid treatment of AIDS-related mania. J Clin Psychiatry 58: 406\u2013407","journal-title":"J Clin Psychiatry"},{"key":"353_CR79","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1345\/aph.19014","volume":"33","author":"HR Jennings","year":"1999","unstructured":"Jennings HR, Romanelli F (1999) The use of valproic acid in HIV-positive patients. Ann Pharmacother 33: 1113\u20131116","journal-title":"Ann Pharmacother"},{"key":"353_CR80","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1176\/appi.psy.41.5.452","volume":"41","author":"KL Cozza","year":"2000","unstructured":"Cozza KL, Swanton EJ, Humphreys CW (2000) Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: A case report. Psychosomatics 41: 452\u2013453","journal-title":"Psychosomatics"},{"key":"353_CR81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00126334-200004010-00003","volume":"23","author":"S Low-Beer","year":"2000","unstructured":"Low-Beer S, Chan K, Yip B, Wood E, Montaner JSG, O'Shaughnessy MV, Hogg RS (2000) Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr 23: 295\u2013301","journal-title":"J Acquir Immune Defic Syndr"},{"key":"353_CR82","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/apc.2005.19.813","volume":"19","author":"S Himmelhoch","year":"2005","unstructured":"Himmelhoch S, Medoff DR (2005) Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS 19: 813\u2013822","journal-title":"AIDS Patient Care STDS"},{"key":"353_CR83","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/ajp.151.4.516","volume":"151","author":"JG Rabkin","year":"1994","unstructured":"Rabkin JG, Rabkin R, Harrison W, Wagner G (1994) Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. Am J Psychiatry 151: 516\u2013523","journal-title":"Am J Psychiatry"},{"key":"353_CR84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/ajp.156.1.101","volume":"156","author":"JG Rabkin","year":"1999","unstructured":"Rabkin JG, Wagner GJ, Rabkin R (1999) Fluoxetine treatment for depression in patients with HIV and AIDS: A randomized, placebo-controlled trial. Am J Psychiatry 156: 101\u2013107","journal-title":"Am J Psychiatry"},{"key":"353_CR85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4088\/JCP.v59n0502","volume":"59","author":"S Zisook","year":"1998","unstructured":"Zisook S, Peterkin J, Goggin KJ, Sledge P, Atkinson JH, Grant I (1998) Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. J Clin Psychiatry 59: 217\u2013224","journal-title":"J Clin Psychiatry"},{"key":"353_CR86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1176\/ajp.155.3.367","volume":"155","author":"AJ Elliott","year":"1998","unstructured":"Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP (1998) Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry 155: 367224372","journal-title":"Am J Psychiatry"},{"key":"353_CR87","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.psy.45.3.210","volume":"45","author":"MB Currier","year":"2004","unstructured":"Currier MB, Molina G, Kato M (2004) Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: A prospective study. Psychosomatics 45: 210\u2013216","journal-title":"Psychosomatics"},{"key":"353_CR88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-979597","volume":"28","author":"B Grassi","year":"1995","unstructured":"Grassi B, Gambini O, Scarone S (1995) Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects. Pharmacopsychiatry 28: 93\u201394","journal-title":"Pharmacopsychiatry"},{"key":"353_CR89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00004714-200004000-00023","volume":"20","author":"AJ Elliott","year":"2000","unstructured":"Elliott AJ, Roy-Byrne PP (2000) Mirtazapine for depression in patients with human immunodeficiency virus. J Clin Psychopharmacol 20: 265\u2013267","journal-title":"J Clin Psychopharmacol"},{"key":"353_CR90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v64n0411","volume":"64","author":"AS Carvalhal","year":"2003","unstructured":"Carvalhal AS, de Abreu PB, Spode A, Correa J, Kapczinski F (2003) An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry 64: 421\u2013424","journal-title":"J Clin Psychiatry"},{"key":"353_CR91","first-page":"173","volume":"38","author":"F Fernandez","year":"1997","unstructured":"Fernandez F, Levy J (1997) Efficacy of venlafaxine in HIV-depressive disorders. Psychosomatics 38: 173\u2013174","journal-title":"Psychosomatics"},{"key":"353_CR92","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archinte.161.3.411","volume":"161","author":"W Breitbart","year":"2000","unstructured":"Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J (2000) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161: 411\u2013420","journal-title":"Arch Intern Med"},{"key":"353_CR93","first-page":"195","volume":"10","author":"HB Rothenh\u00e4usler","year":"2005","unstructured":"Rothenh\u00e4usler HB (2005) Pharmako- und psychotherapeutische Ans\u00e4tze bei depressiven Patienten mit somatischen Krankheiten. Psychotherapie 10: 195\u2013204","journal-title":"Psychotherapie"},{"key":"353_CR94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007691-200202000-00005","volume":"24","author":"PM Rainey","year":"2001","unstructured":"Rainey PM (2001) HIV drug interactions: the good, the bad, and the other. Ther Drug Monit 24: 26\u201331","journal-title":"Ther Drug Monit"},{"key":"353_CR95","series-title":"Drug interaction principles for medical practice","first-page":"S139","volume-title":"The Cytochrome P450 system","author":"KL Cozza","year":"2001","unstructured":"Cozza KL, Armstrong SC (2001) Infectious diseases. In: Cozza KL, Armstrong SC (Hrsg) The Cytochrome P450 system. Drug interaction principles for medical practice. Am Psychiatric Press, Washington DC, S139\u2013S162"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-006-0353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0353-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T21:28:43Z","timestamp":1736717323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-006-0353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":95,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s10354-006-0353-y","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}